Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sub Surface Waste Management (SSWM) was an environmental biotechnology company that specialized in the remediation of contaminated soil and groundwater. A subsidiary of U.S. Microbics, the company utilized proprietary microbial technology to provide engineered solutions for the cleanup of toxic waste releases. Its core business involved the application of 'bioremediation,' using specific microbial blends to degrade pollutants in-situ or through its Bio-Raptor ex-situ treatment system. SSWM served a variety of industrial and government clients, primarily in the United States and Mexico, before undergoing a corporate name change to Green Mountain Development Corp in 2008. While the company operated within the biotechnology sector, its focus was exclusively on environmental engineering rather than human healthcare.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sub Surface Waste Management.